These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20110160)

  • 21. Effects of a healthy Nordic diet on cardiovascular risk factors in hypercholesterolaemic subjects: a randomized controlled trial (NORDIET).
    Adamsson V; Reumark A; Fredriksson IB; Hammarström E; Vessby B; Johansson G; Risérus U
    J Intern Med; 2011 Feb; 269(2):150-9. PubMed ID: 20964740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.
    Saltissi D; Morgan C; Rigby RJ; Westhuyzen J
    Am J Kidney Dis; 2002 Feb; 39(2):283-90. PubMed ID: 11840368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Appetite for life: an evaluation of a primary care lifestyle programme.
    Cutler L; King B; McCarthy N; Hamilton G; Cook L
    J Prim Health Care; 2010 Dec; 2(4):281-7. PubMed ID: 21125068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
    Farnier M; Averna M; Missault L; Vaverkova H; Viigimaa M; Massaad R; Vandormael K; Johnson-Levonas AO; Brudi P
    Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
    Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
    Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study).
    Garmendia F; Brown AS; Reiber I; Adams PC
    Curr Med Res Opin; 2000; 16(3):208-19. PubMed ID: 11191012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.
    Andersson C; Weeke P; Fosbøl EL; Brendorp B; Køber L; Coutinho W; Sharma AM; Van Gaal L; Finer N; James WP; Caterson ID; Rode RA; Torp-Pedersen C; ;
    Metabolism; 2009 Aug; 58(8):1109-15. PubMed ID: 19454355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of an indirect effect model to describe the LDL cholesterol-lowering effect by statins in hypercholesterolaemic patients.
    Faltaos DW; Urien S; Carreau V; Chauvenet M; Hulot JS; Giral P; Bruckert E; Lechat P
    Fundam Clin Pharmacol; 2006 Jun; 20(3):321-30. PubMed ID: 16671968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cultural factors and patients' adherence to lifestyle measures.
    Serour M; Alqhenaei H; Al-Saqabi S; Mustafa AR; Ben-Nakhi A
    Br J Gen Pract; 2007 Apr; 57(537):291-5. PubMed ID: 17394732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consumption of cod and weight loss in young overweight and obese adults on an energy reduced diet for 8-weeks.
    Ramel A; Jonsdottir MT; Thorsdottir I
    Nutr Metab Cardiovasc Dis; 2009 Dec; 19(10):690-6. PubMed ID: 19356912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recommendations for treatment of high blood cholesterol. The National Cholesterol Education Program Adult Treatment Panel.
    Ernst ND; LaRosa JC
    Bol Asoc Med P R; 1988 Jul; 80(7):258-61. PubMed ID: 3166669
    [No Abstract]   [Full Text] [Related]  

  • 34. [Weight-control intervention in overweight subjects at high risk of cardiovascular disease: a trial of a public health practical training program in a medical school].
    Okuda N; Okamura T; Kadowaki T; Tanaka T; Ueshima H
    Nihon Koshu Eisei Zasshi; 2004 Jul; 51(7):552-60. PubMed ID: 15446673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A text messaging-assisted randomized lifestyle weight loss clinical trial among overweight adults in Beijing.
    Lin PH; Wang Y; Levine E; Askew S; Lin S; Chang C; Sun J; Foley P; Wang H; Li X; Bennett GG
    Obesity (Silver Spring); 2014 May; 22(5):E29-37. PubMed ID: 24375969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypercholesterolemia and cardiovascular disease: What to do before initiating pharmacological therapy.
    Föger B; Jennings C; Pirillo A; Tokgözoğlu L; Pirro M; Catapano AL
    Atheroscler Suppl; 2020 Dec; 42():e25-e29. PubMed ID: 33589220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. USPSTF: Lifestyle counseling advised for overweight, obese adults with other cardiovascular risk factors.
    Stephenson J
    JAMA; 2014 Sep; 312(11):1085. PubMed ID: 25226462
    [No Abstract]   [Full Text] [Related]  

  • 38. Can intervention modify adverse lifestyle variables in a rheumatoid population? Results of a pilot study.
    Gordon MM; Thomson EA; Madhok R; Capell HA
    Ann Rheum Dis; 2002 Jan; 61(1):66-9. PubMed ID: 11779763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serum lipid levels in hypercholesterolemic post-menopausal women treated with transdermal sequential combined hormone replacement therapy only or in combination with simvastatin].
    Dobrzycka B; Lenczewski A; Dobrzycki S; Terlikowski S; Mirończuk J; Nowak A; Kulikowski M
    Ginekol Pol; 2000 Sep; 71(9):1075-8. PubMed ID: 11082978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Strategies for cardiovascular prevention in children].
    Spinelli A; Nardone P; Lamberti A; Baglio G;
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):87S-89S. PubMed ID: 20879489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.